WHO steps ahead for in­creas­ing HIV treat­ment

BioSpectrum (Asia) - - Who News -

WHO has pre­qual­i­fied the first HIV self-test in a move to in­crease HIV di­ag­no­sis and treat­ment. The prod­uct, OraQuick HIV

Self-Test (man­u­fac­tured by OraSure Tech­nolo­gies Inc.) uses oral fluid as a spec­i­men and pro­vides re­sults in as lit­tle as twenty min­utes.

The move also marks a sig­nif­i­cant step in al­low­ing coun­tries to im­ple­ment WHO guide­lines, re­leased in 2016, rec­om­mend­ing HIV self-test­ing as a com­ple­men­tary ap­proach to reach those who re­main un­di­ag­nosed due to fear of stigma and dis­crim­i­na­tion.

In 2016, an es­ti­mated 30% of all peo­ple liv­ing with HIV re­mained un­aware of their HIV sta­tus, many from higher risk pop­u­la­tions who are ei­ther less likely to ap­proach a health fa­cil­ity or are un­able to do so.

There is cur­rently great interest from the in­ter­na­tional community in de­ploy­ing tests in­tended for HIV self-test­ing, with nu­mer­ous coun­tries hav­ing de­vel­oped na­tional guide­lines and plans for im­ple­men­ta­tion.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.